HL7 Parser
Parse Message
Something wrong with HL7 Message. 'Can't parse message beginning FHS|^~\\&|Clinical Reference Laboratory|CLS|||2026'
Parsed HL7v2 Message
Original Message
FHS|^~\\&|Clinical Reference Laboratory|CLS|||202601021756\r\nMSH|^~\\&|Clinical Reference Laboratory|CLS^CRL, 8433 Quivira Road Lenexa, Kansas 66215^L|||202601021756||ORU|1|P|2.3|||NE|NE|US|ASCII|ENG\r\nPID|1|00000177ED|6121883916|N/S|TEST^DISNEY||200011300000|M|||||N/S|N/S|N/S||||N/S|N/S\r\nNTE|1|L|ACCOUNT_CODE_NAMES\\S\\BETR HEALTH\\T\\WELLNESS\\T\\\\T\\\r\nNTE|2|L|TRANSMIT_DATE\\S\\202601021756\r\nNTE|3|L|12J\\S\\TESTING PERFORMED AT:\\.br.\\CLINICAL REFERENCE LABORATORY\\.br.\\8433 QUIVIRA ROAD, LENEXA, KS 66215 (913)492-3652\\.br.\\SHAWN R. CLINTON, PHD DABCC\\.br.\\CLIA #17D0667123 CAP #3021101 PFI#4112\r\nNTE|4|L|I49\\S\\ALL TESTS PERFORMED ON BLOOD UNLESS OTHERWISE SPECIFIED.\r\nNTE|5|L|Tasso Kit Order #11cb5d3a-93f6-41d2-af99-f1105d893caf\r\nNTE|6|L|00000177ED\\S\\CONTAINER ID\r\nPR1|1||Y552^CHD/ALB/A1C/CRP/VITD/VITB12|||D\r\nOBR|1|00000177ED|||||202601021843|||CLS..^N/S^N/S|L|||202601021415||WLZ.WELL||||H\\S\\HEALTH FAIR/WELLNESS|CHEMISTRIES|202601021446||LAB|F||||||HR^HEALTH RISK ASSESSMENT|DIALA HAMED|COMPUTER\r\nOBX|1|SN|T511^ALBUMIN||^3.3|g/dL|3.2-5.5||||F\r\nOBX|2|SN|T226^VITAMIN B-12||^311|pg/mL|211-911||||F\r\nOBX|3|ST|T791^VITAMIN D 25 HYDROXY||HIGH|ng/mL|||||F\r\nOBX|3|SN|T791^VITAMIN D 25 HYDROXY||^88.20|ng/mL|||||F\r\nNTE|1|L|Interpretive guidelines for Vitamin D (25-Hydroxy):\r\nNTE|2|L|>80 ng/mL ....Potential Toxicity\r\nNTE|3|L|26-80 ng/mL...Optimum Level\r\nNTE|4|L|10-25 ng/mL...Mild to Moderate Deficiency\r\nNTE|5|L|<10 ng/mL.....Severe Deficiency\r\nOBX|4|SN|T049^HEMOGLOBIN A1C||^5.3|%|||||F\r\nNTE|1|L|Normal Less than 5.7%\r\nNTE|2|L|Prediabetes 5.7% - 6.4%\r\nNTE|3|L|Diabetes 6.5% or higher\r\nOBR|2|00000177ED|||||202601021843|||CLS..^N/S^N/S|L|||202601021415||WLZ.WELL||||H\\S\\HEALTH FAIR/WELLNESS|CARDIAC PROFILE|202601021446||LAB|F||||||HR^HEALTH RISK ASSESSMENT|DIALA HAMED|COMPUTER\r\nOBX|5|SN|T514^HIGH DENSITY LIPOPROTEIN(HDL)||^74|mg/dL|40-75||||F\r\nOBX|6|SN|T516^TRIGLYCERIDES||^104|mg/dL|10-150||||F\r\nOBX|7|SN|T513^CHOLESTEROL||^190|mg/dL|120-199||||F\r\nOBX|8|SN|T517^VERYLOW DENSITY LIPO. (VLDL)||^20|mg/dL|5-40||||F\r\nOBX|9|SN|T518^LOW DENSITY LIPOPROTEIN (LDL)||^95|mg/dL|50-129||||F\r\nOBR|3|00000177ED|||||202601021843|||CLS..^N/S^N/S|L|||202601021415||WLZ.WELL||||H\\S\\HEALTH FAIR/WELLNESS|SEROLOGY|202601021446||LAB|F||||||HR^HEALTH RISK ASSESSMENT|DIALA HAMED|COMPUTER\r\nOBX|10|SN|K206^HS-CRP||^0.4|mg/dL|0.0-0.5||||F\r\nPV1|1\r\nDSP|1||02-Jan-2026 Clinical Reference Laboratory 17:56\r\nDSP|2|| CLIA #17D0667123, CAP #3021101\r\nDSP|3\r\nDSP|4||BETR HEALTH NAME: TEST, DISNEY SAMPLE ID: 21883916\r\nDSP|5||DIALA HAMED DOB: 11/30/00 (AGE: 25 YRS) COLLECTED: 01/02/26\r\nDSP|6||1 GLENWOOD AVE #5 ID: N/S RECEIVED: 01/02/26\r\nDSP|7||RALEIGH, NC 27603 GENDER: MALE REPORTED: 01/02/26\r\nDSP|8|| SLIP ID: 00000177ED FAX: N/S\r\nDSP|9||PH: (919) 961-2302 SPONSOR: 00000177ED\r\nDSP|10||COLL. SITE ID: N/S BRANCH: WELLNESS\r\nDSP|11\r\nDSP|12|| REASON FOR TESTING: HEALTH RISK ASSESSMENT\r\nDSP|13\r\nDSP|14||TESTING PERFORMED AT:\r\nDSP|15||CLINICAL REFERENCE LABORATORY\r\nDSP|16||8433 QUIVIRA ROAD, LENEXA, KS 66215 (913)492-3652\r\nDSP|17||SHAWN R. CLINTON, PHD DABCC\r\nDSP|18||CLIA #17D0667123 CAP #3021101 PFI#4112\r\nDSP|19\r\nDSP|20||ALL TESTS PERFORMED ON BLOOD UNLESS OTHERWISE SPECIFIED.\r\nDSP|21\r\nDSP|22||GENERAL COMMENT(S):\r\nDSP|23|| Tasso Kit Order #11cb5d3a-93f6-41d2-af99-f1105d893caf\r\nDSP|24\r\nDSP|25||CHEMISTRIES RESULT / STATUS CUTOFF/EXPECTED VALUES\r\nDSP|26||----------- ------------------- ----------------------\r\nDSP|27|| ALBUMIN 3.3 3.2-5.5 g/dL\r\nDSP|28|| VITAMIN B-12 311 211-911 pg/mL\r\nDSP|29|| VITAMIN D 25 HYDROXY 88.20 HIGH\r\nDSP|30\r\nDSP|31|| Interpretive guidelines for Vitamin D (25-Hydroxy):\r\nDSP|32|| >80 ng/mL ....Potential Toxicity\r\nDSP|33|| 26-80 ng/mL...Optimum Level\r\nDSP|34|| 10-25 ng/mL...Mild to Moderate Deficiency\r\nDSP|35|| <10 ng/mL.....Severe Deficiency\r\nDSP|36\r\nDSP|37|| HEMOGLOBIN A1C 5.3\r\nDSP|38\r\nDSP|39|| Normal Less than 5.7%\r\nDSP|40|| Prediabetes 5.7% - 6.4%\r\nDSP|41|| Diabetes 6.5% or higher\r\nDSP|42\r\nDSP|43||CARDIAC PROFILE RESULT / STATUS CUTOFF/EXPECTED VALUES\r\nDSP|44||--------------- ------------------- ----------------------\r\nDSP|45|| HIGH DENSITY LIPOPROTEIN(HDL 74 40-75 mg/dL\r\nDSP|46|| TRIGLYCERIDES 104 10-150 mg/dL\r\nDSP|47|| CHOLESTEROL 190 120-199 mg/dL\r\nDSP|48|| VERYLOW DENSITY LIPO. (VLDL) 20 5-40 mg/dL\r\nDSP|49|| LOW DENSITY LIPOPROTEIN (LDL 95 50-129 mg/dL\r\nDSP|50\r\nDSP|51\r\nDSP|52|| Page 1\r\nDSP|53\r\nDSP|54|| Copyright 2026 Clinical Reference Laboratory. All Rights Reserved.\r\nDSP|55|| 8433 Quivira Road. Lenexa, Kansas 66215. (913) 492-3652\r\nDSP|56\r\nDSP|57|| FCB: CLS.WLZ.WELL\r\nDSP|58||\\X0C\\\r\nDSP|59||02-Jan-2026 Clinical Reference Laboratory 17:56\r\nDSP|60|| CLIA #17D0667123, CAP #3021101\r\nDSP|61\r\nDSP|62||BETR HEALTH NAME: TEST, DISNEY SAMPLE ID: 21883916\r\nDSP|63||DIALA HAMED DOB: 11/30/00 (AGE: 25 YRS) COLLECTED: 01/02/26\r\nDSP|64||1 GLENWOOD AVE #5 ID: N/S RECEIVED: 01/02/26\r\nDSP|65||RALEIGH, NC 27603 GENDER: MALE REPORTED: 01/02/26\r\nDSP|66|| SLIP ID: 00000177ED FAX: N/S\r\nDSP|67||PH: (919) 961-2302 SPONSOR: 00000177ED\r\nDSP|68||COLL. SITE ID: N/S BRANCH: WELLNESS\r\nDSP|69\r\nDSP|70|| REASON FOR TESTING: HEALTH RISK ASSESSMENT\r\nDSP|71\r\nDSP|72||TESTING PERFORMED AT:\r\nDSP|73||CLINICAL REFERENCE LABORATORY\r\nDSP|74||8433 QUIVIRA ROAD, LENEXA, KS 66215 (913)492-3652\r\nDSP|75||SHAWN R. CLINTON, PHD DABCC\r\nDSP|76||CLIA #17D0667123 CAP #3021101 PFI#4112\r\nDSP|77\r\nDSP|78||ALL TESTS PERFORMED ON BLOOD UNLESS OTHERWISE SPECIFIED.\r\nDSP|79\r\nDSP|80||GENERAL COMMENT(S):\r\nDSP|81|| Tasso Kit Order #11cb5d3a-93f6-41d2-af99-f1105d893caf\r\nDSP|82\r\nDSP|83||SEROLOGY RESULT / STATUS CUTOFF/EXPECTED VALUES\r\nDSP|84||-------- ------------------- ----------------------\r\nDSP|85|| HS-CRP 0.4 0.0-0.5 mg/dL\r\nDSP|86\r\nDSP|87|| THE CDC/AHA RECOMMENDS THE FOLLOWING HSCRP CUTOFF POINTS\r\nDSP|88|| FOR CVD RISK ASSESSMENT:\r\nDSP|89|| HSCRP LEVEL (MG/DL) HSCRP LEVEL(MG/L) RELATIVE RISK\r\nDSP|90|| <0.1 <1.0 LOW\r\nDSP|91|| 0.1 - 0.3 1.0 - 3.0 AVERAGE\r\nDSP|92|| >0.3 >3.0 HIGH\r\nDSP|93\r\nDSP|94\r\nDSP|95|| LAB DIRECTOR: SHAWN R. CLINTON, PHD, DABCC\r\nDSP|96\r\nDSP|97\r\nDSP|98\r\nDSP|99|| ELECTRONICALLY REVIEWED BY COMPUTER\r\nDSP|100\r\nDSP|101\r\nDSP|102\r\nDSP|103\r\nDSP|104\r\nDSP|105\r\nDSP|106\r\nDSP|107\r\nDSP|108\r\nDSP|109\r\nDSP|110|| Page 2\r\nDSP|111\r\nDSP|112|| Copyright 2026 Clinical Reference Laboratory. All Rights Reserved.\r\nDSP|113|| 8433 Quivira Road. Lenexa, Kansas 66215. (913) 492-3652\r\nDSP|114\r\nDSP|115|| FCB: CLS.WLZ.WELL\r\nDSP|116\r\nDSP|117|| [ end of report ]\r\nDSP|118\r\nFTS|1|CRL HL7 Format Implementation\r\n
Parsed Message
No locations have been defined yet!
Parse another Message